Will support legislation to prohibit certain uses of xylazine.

Josh Riley · New York · Democratic

policy impact 0.55 specificity 0.72 extraction confidence 75%

Commitment kind: action. Promised action: Support H.R. 1266, legislation to prohibit certain uses of xylazine.. Promised outcome: not established. Deadline: unknown; not assumed expired. As U.S. Representative for New York's 19th District in the 119th Congress, Riley is listed as a cosponsor of H.R. 1266, the Combating Illicit Xylazine Act.

Contest this claim

Occurrences

Zoe Lofgren (CA); Josh Riley (NY); John Garamendi (CA); Gabe Vasquez (NM); Marie Gluesenkamp Perez (WA); Scott DesJarlais (TN); Glenn Ivey (MD); Jack Bergman (MI); Valerie P. Foushee (NC); Mark Alford (MO); Nicholas A. Langworthy (NY); Lori Trahan (MA); Tim Moore (NC); Josh Gottheimer (NJ); Chuck Edwards (NC); Laura Gillen (NY); Ryan Mackenzie (PA); Sheri Biggs (SC); John Joyce (PA); Craig A. Goldman (TX); Monica De La Cruz (TX); Scott H. Peters (CA); Dina Titus (NV); Maggie Goodlander (NH); Steven Horsford (NV) Committees Committee on Energy and Commerce (Standing), Committee on the Judiciary (Standing) Report Number H. Rept.119-816 United States Code References 21 U.S.C. 355, 801, 802, 812, 827, 841 and 960 28 U.S.C. 994(p)

GovInfo lists Josh Riley as a cosponsor of H.R. 1266, the Combating Illicit Xylazine Act, whose full title is to prohibit certain uses of xylazine.

H.R. 1266 (RH) - Combating Illicit Xylazine Act - BILLS-119hr1266rh | Content Details | GovInfo
primary · other · model gpt-5.5

Evidence

unverified · Source version 92705 · locator unknown

12/09/2025 - Rep. Riley, Josh [D-NY-19]

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Congress.gov records Riley joining H.R.1266 as a cosponsor on December 9, 2025, during his current House term. This establishes concrete legislative support; enactment remains unresolved.

unresolved same_term A for effort

Cosponsors - H.R.1266 - 119th Congress (2025-2026): Combating Illicit Xylazine Act | Congress.gov | Library of Congress
secondary · model gpt-6.1-sol · confidence 99%

Contest this evidence item

verified · Source version 92707 · locator 7179

Passed the House of Representatives September 15, 2026.

Fetched verbatim passage. AI summary (separate from source): The official bill records House passage and receipt in the Senate on September 16. It would place xylazine in Schedule III while preserving specified lawful animal uses. Searches for October 15–17 found no newer official action establishing enactment, reversal, or abandonment; the policy outcome remains unresolved.

unresolved same_term

H.R.1266 — Combating Illicit Xylazine Act, Placed on Calendar Senate
secondary · model gpt-6.1-sol · confidence 95%

Contest this evidence item

Assessments

Public state: pending As of 2026-10-17 · verified · . Original AI recommendation (not independently established): unresolved. unknown

This promise concerns supporting legislation, so enactment is unnecessary for fulfillment. However, the verified original passage merely lists Riley’s name without identifying his role. Evidence 68251 establishes House passage but no action by Riley. The explicit cosponsorship evidence is unverified, leaving both fulfillment and attributable effort unproven.

provider codex_cli · model gpt-6.1-sol · confidence 94%